Applied Materials leads Zacks' latest Analyst Blog, with strong semiconductor momentum offset by rising trade and cost ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Puerto Rican financial services company OFG Bancorp (NYSE:OFG) met Wall Streets revenue expectations in Q4 CY2025, with sales up 1.9% year on year to $185.4 million. Its non-GAAP profit of $1.27 per ...

Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...

This article discusses the best dividend aristocrats right now.

ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a leading healthcare company, today unveiled Libre Assist,1 a groundbreaking feature within the Libre app5 designed to help the ...

CLEVELAND, Ohio — They couldn’t seem more different on the surface: Kevin Stefanski, the methodical, risk-averse head coach who abhors turnovers, and Shedeur Sanders, the improvisational rookie ...

Abbott Diabetes Care has recalled certain glucose monitoring sensors after reports of seven deaths and more than 700 injuries possibly linked to malfunctioning devices that could provide inaccurate ...

Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus devices have been recalled Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been working at PEOPLE since 2024, and was previously ...

Millions of people rely on continuous glucose monitors to help manage diabetes. But a new alert from the U.S. Food and Drug Administration warns that some sensors from Abbott may give incorrect blood ...

Certain glucose monitors from Abbott Diabetes Care are providing users with incorrect glucose readings, an error that has been linked with the deaths of at least ...